Crossmark

Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

Crossref DOI link: https://doi.org/10.1016/j.arbres.2023.08.017

Published Print: 2023-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Almonacid-Sánchez, Carlos

Cosío, Borja G. http://orcid.org/0000-0002-6388-8209
Trisán-Alonso, Andrea

Callejas-González, Francisco Javier

Cisneros, Carolina

Martínez-Moragón, Eva

Plaza Moral, Vicente

Vera, Elisabeth

Soto-Campos, José Gregorio

Martínez-Rivera, Carlos

Alcazar-Navarrete, Bernardino

Urrutia Landa, Isabel

García-Rivero, Juan Luis

Padilla Galo, Alicia

Álvarez-Gutierrez, Francisco

Ramos-González, Jacinto

Carretero-Gracia, José Ángel

Lluch, Inmaculada

Puente, Luis

Andujar-Espinosa, Rubén

Pérez-de-Llano, Luis
Funding

Funding for this research was provided by:

SEPAR

AstraZeneca España
License Information

Text and Data Mining valid from 2023-12-01
More Information

This article is maintained by: Elsevier

Article Title: Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2023.08.017

Content Type: simple-article

Copyright: © 2023 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.